missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human CD9-LEL Fc Chimera Protein
Click to view available options
Quantity:
100 μg
Unit Size:
50µg
Description
The Recombinant Human CD9-LEL Fc Chimera Protein is derived from CHO. The Recombinant Human CD9-LEL Fc Chimera Protein has been validated for the following applications: Bioactivity.
Specifications
Specifications
| Accession Number | P21926 |
| For Use With (Application) | Bioactivity |
| Gene ID (Entrez) | 928 |
| Molecular Weight (g/mol) | 36.3 kDa |
| Quantity | 100 μg |
| Source | Chinese Hamster Ovary cell line,CHO-derived human CD9 protein, (N-terminus) Human IgG1 MD +(Pro100-Lys330) IEGR Human CD9-LEL (Ser112-Ile195) Accession &Num; P21926 (C-terminus) |
| Storage Requirements | 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution. |
| Regulatory Status | RUO |
| Endotoxin Concentration | <0.10 EU per 1 μg of the protein by the LAL method. |
| Specific Reactivity | CD9 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction